tirzepatide cause anxiety Can anxiety? What the clinical evidence actually shows GLP-1s linked to lower rates

True non-responders: uncertain outcomes If semaglutide produced absolutely no appetite suppression, no metabolic improvement, and no weight loss even at the maximum 2.4mg dose over 16 or more weeks, you may have fundamental resistance to GLP-1 receptor agonism

How GI side effects quietly sabotage intimacy This section addresses the elephant in the room that nobody wants to discuss

In the case of GLP-1 two most prominent limitations to drawing specific conclusions about the role of the peptide in regulation of reward are (1) nausea or visceral illness and (2) the non-specific motor disturbance

Remaining at 1.0 mg is a valid clinical choice if you achieve your weight loss target and tolerate the dose well

When appetite is low, focus on protein shakes, smoothies, and nutrient-dense small meals